A Study of Mevrometostat With Enzalutamide in People With Prostate Cancer Who Have Previously Received Androgen Receptor Pathway Inhibitor Therapy

Name: A Study of Mevrometostat With Enzalutamide in People With Prostate Cancer Who Have Previously Received Androgen Receptor Pathway Inhibitor Therapy
Published: 2026
License: Public Domain

Prostate Cancer Clinical Trials Consortium · 2026

ClinicalTrials.gov · Datasets · License: Public Domain · 2026

Open Source ↗

prostate-cancer

metastatic castrate resistant prostate cancer (mcrpc), prostate cancer (adenocarcinoma), mevrometostat, ezh2 inhibitor, enzalutamide, arpi resistance, moment, mcrpc, prostate cancer, interventional, phase2

This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

A Study of Mevrometostat With Enzalutamide in People With Prostate Cancer Who Have Previously Received Androgen Receptor Pathway Inhibitor Therapy

Related documents